Key references: Overview of systemic MHT

Boardman HM, Hartley L, Eisinga A, Main C, Roque i Figuls M, Bonfill Cosp X, et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev 2015;(3):CD002229. https://www.ncbi.nlm.nih.gov/pubmed/25754617
Collaborative Group on Hormonal Factors in Breast Cancer. Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol 2012;13(11):1141–51. https://www.ncbi.nlm.nih.gov/pubmed/23084519
POI Guideline Development Group. Management of women with premature ovarian insufficiency. Guideline of the European Society of Human Reproduction and Embryology (ESHRE). Grimbergen, Belgium: ESHRE; 2015. https://www.eshre.eu/Guidelines-and-Legal/Guidelines/Management-of-premature-ovarian-insufficiency.aspx
Santen RJ, Allred DC, Ardoin SP, Archer DF, Boyd N, Braunstein GD, et al. Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab 2010;95(7 Suppl 1):s1–s66. https://www.ncbi.nlm.nih.gov/pubmed/20566620
Sitruk-Ware R. The levonorgestrel intrauterine system for use in peri- and postmenopausal women. Contraception 2007;75(6 Suppl):S155–60. https://www.ncbi.nlm.nih.gov/pubmed/17531609
Xu X, Jones M, Mishra GD. Age at natural menopause and development of chronic conditions and multimorbidity: results from an Australian prospective cohort. Hum Reprod 2020;35(1):203–11. https://www.ncbi.nlm.nih.gov/pubmed/31955198